XML 69 R25.htm IDEA: XBRL DOCUMENT
v3.24.3

Accrued Liabilities (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2024
Accrued Liabilities, Current [Abstract] |
Schedule of Accrued Liabilities | Accrued liabilities as of September 30, 2024 and December 31, 2023 consisted of the following (in thousands):
| September 30, 2024 |  | December 31, 2023
Contract research organization costs | $ | 59,809 |  |  | $ | 50,737 |
Other clinical study related costs | 1,496 |  |  | 3,724 |
Manufacturing and drug supply | 2,291 |  |  | 9,705 |
Compensation and benefits | 29,684 |  |  | 17,030 |
Professional fees | 23,095 |  |  | 6,814 |
Gross to net accrued liabilities | 7,816 |  |  | — |
Other | 6,812 |  |  | 1,970 |
Total accrued liabilities | $ | 131,003 |  |  | $ | 89,980 |

X
- References No definition available. + Details
Name: | us-gaap_AccruedLiabilitiesCurrentAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the components of accrued liabilities. + References No definition available. + Details
Name: | us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration